NeuroMetrix is headquartered in Woburn, Massachusetts.
NeuroMetrix disclosed revenue of 6M USD for 2023 and 8M USD for 2022.
NeuroMetrix is a medical products company.
NeuroMetrix was founded in 1996.
4B Gill Street,
Woburn, Massachusetts
01801
United States,
(781) 890-9989
www.neurometrix.com
NeuroMetrix is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions, including mobile apps, enterprise software, and cloud-based systems. It operates two commercial brands Quell (wearable neuromodulation platform) and DPNCheck (point-of-care screening test for peripheral neuropathy). NeuroMetrix was founded in 1996 and is based in Woburn, Massachusetts.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $10M | $10M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
